Related Experiment Video

Updated: Aug 18, 2026

Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay
12:26

Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay

Published on: May 3, 2018

CAK-Cyclin-dependent Activating Kinase: a key kinase in cell cycle control and a target for drugs?

Graziano Lolli1, Louise N Johnson

  • 1Laboratory of Molecular Biophysics, Department of Biochemistry, University of Oxford, Oxford, UK. graziano@biop.ox.ac.uk

Cell Cycle (Georgetown, Tex.)
|May 7, 2005
PubMed

Insights

Cyclin-dependent kinase (CDK) Activating Kinase (CAK), composed of CDK7, Cyclin H, and MAT1, regulates cell cycle progression. Its role in transcription and cell cycle suggests CDK7 as a cancer therapy target, though toxicity is a concern.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Biochemistry

Background:

  • The Cyclin-dependent kinase (CDK) Activating Kinase (CAK) complex, comprising CDK7, Cyclin H, and MAT1, is crucial for cell cycle regulation.
  • CAK phosphorylates and activates CDK1, CDK2, CDK4, and CDK6, essential for cell cycle progression.
  • CAK is also a subunit of the general transcription factor TFIIH, participating in transcription initiation and promoter clearance.

Purpose of the Study:

  • To review the multifaceted roles of CAK in various biological processes.
  • To evaluate the potential of CDK7 as a pharmacological target for cancer therapy.
  • To discuss the implications of CDK7's dual role in cell cycle and transcription for inhibitor design.

Main Methods:

  • Literature review of CAK's functions in cell cycle and transcription.
  • Analysis of the biological evidence supporting CDK7 as a therapeutic target.
  • Consideration of structural data for designing specific CDK inhibitors.

Main Results:

  • CDK7's essential role in cell cycle progression highlights its potential as a cancer drug target.
  • CAK's involvement in transcription, alongside its ubiquitous presence, raises concerns about potential inhibitor toxicity.
  • The recently elucidated structure of CDK7 enables the design of inhibitors with tailored specificity.

Conclusions:

  • CDK7 is a promising target for cancer therapy due to its critical role in cell cycle regulation.
  • Balancing therapeutic efficacy with potential toxicity is key when developing CDK7 inhibitors.
  • Targeting CDK7 offers a potential strategy for cancer treatment, warranting further investigation into inhibitor development.

More Related Videos

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors10:33

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols12:02

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols

Published on: June 6, 2017

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
Positive Regulator Molecules01:45

Positive Regulator Molecules

To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...